Influenza virus
infection and the resulting complications are a significant global public health problem. Improving humoral immunity to
influenza is the target of current conventional
influenza vaccines, however, these are generally not cross-protective. On the contrary, cell-mediated immunity generated by primary
influenza infection provides substantial protection against serologically distinct viruses due to recognition of cross-reactive
T cell epitopes, often from internal
viral proteins conserved between viral subtypes. Efforts are underway to develop a
universal flu vaccine that would stimulate both the humoral and cellular immune responses leading to long-lived memory. Such a universal
vaccine should target conserved influenza virus antibody and
T cell epitopes that do not vary from strain to strain. In the last decade, immunoproteomics, or the direct identification of HLA class I presented
epitopes, has emerged as an alternative to the motif prediction method for the identification of
T cell epitopes. In this study, we used this method to uncover several cross-specific MHC class I specific
T cell epitopes naturally presented by
influenza A-infected cells. These conserved
T cell epitopes, when combined with a cross-reactive antibody
epitope from the ectodomain of
influenza M2, generate cross-strain specific cell mediated and humoral immunity. Overall, we have demonstrated that conserved
epitope-specific CTLs could recognize multiple
influenza strain infected target cells and, when combined with a universal antibody
epitope, could generate virus specific humoral and T cell responses, a step toward a universal
vaccine concept. These
epitopes also have potential as new tools to characterize T cell immunity in
influenza infection, and may serve as part of a universal
vaccine candidate complementary to current
vaccines.